The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study.
Rhiem K, Engel C, Graeser M, Zachariae S, Kast K, Kiechle M, Ditsch N, Janni W, Mundhenke C, Golatta M, Varga D, Preisler-Adams S, Heinrich T, Bick U, Gadzicki D, Briest S, Meindl A, Schmutzler RK.
Rhiem K, et al. Among authors: varga d.
Breast Cancer Res. 2012 Dec 7;14(6):R156. doi: 10.1186/bcr3369.
Breast Cancer Res. 2012.
PMID: 23216834
Free PMC article.